
    
      This study will look at the effect of a single does of study medication in three groups. Each
      group will have 6 - 8 subjects with similar levels of hepatic impairment. Group 1 will have
      normal hepatic function. Groups 2 and 3 will be made up of subjects with mild to moderate
      hepatic impairment. Subjects will have blood taken at specific intervals to measure study
      medication levels. Subject participation will last approximately 7 to 9 days.
    
  